A 2-part Trial to Learn More About How BAY1817080 Works, How Safe it is, and What the Right Dose is for Participants With Diabetic Neuropathic Pain

Clinical trial NCT04641273 · TERMINATED

Trial details

NCT number: NCT04641273
Sponsor: Bayer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Start date: 2021-01-22
Primary completion: 2021-09-23
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.